Results 51 to 60 of about 1,252 (192)
Objective: The circulating betatrophin levels in diabetic patients, treated with insulin or with oral hypoglycemic agents, were measured. The correlation between betatrophin levels and the glucose/lipid variables was also analyzed. Material and Methods:
Rasha M. HUSSEIN
doaj +1 more source
Potential Role of ANGPTL4 in the Cross Talk between Metabolism and Cancer through PPAR Signaling Pathway [PDF]
The angiopoietin-like 4 (ANGPTL4) protein belongs to a superfamily of secreted proteins structurally related to factors modulating angiogenesis known as angiopoietins.
Amodeo, V. +6 more
core +6 more sources
Betatrophin association with serum triglyceride levels in obstructive sleep apnea patients
BACKGROUND: Obstructive sleep apnea (OSA) is a common sleep problem, in which patients are at increased risk for metabolic and cardiovascular problems, including metabolic syndrome, diabetes mellitus (DM), and dyslipidemia. Betatrophin is a novel protein
Bunyamin Sertogullarindan +5 more
doaj +1 more source
Palmitate induces mRNA translation and increases ER protein load in islet β-cells via activation of the mammalian target of rapamycin pathway [PDF]
Saturated free fatty acids (FFAs) have complex effects on the islet β-cell, acutely promoting adaptive hyperplasia but chronically impairing insulin release. The acute effects of FFAs remain incompletely defined. To elucidate these early molecular events,
Evans-Molina, Carmella +6 more
core +1 more source
PurposePrevious researches of betatrophin on glucose and lipids metabolism under insulin-resistant condition have reached controversial conclusions. To further identify the possible impact of betatrophin, we measured the circulating betatrophin levels in
Ting Gao +8 more
doaj +1 more source
Japanese patients with NAFLD have significant fibrosis with reduced insulin secretion. These patients also tended to be significantly non‐obese. Abstract Background and Aim Non‐alcoholic fatty liver disease (NAFLD) is typically associated with metabolic syndrome and diabetes, and insulin resistance is involved in its pathogenesis.
Norimasa Araki +11 more
wiley +1 more source
Interplay of atherogenic factors, protein intake and betatrophin levels in obese–metabolic syndrome patients treated with hypocaloric diets [PDF]
The present research evaluated circulating betatrophin levels in obese patients with metabolic syndrome features under energy-restricted weight-loss programs and in normal weight in order to stablish the putative interplay between the levels of this ...
A Alkerwi +49 more
core +3 more sources
Development of a conditionally immortalized human pancreatic β cell line [PDF]
International audienceDiabetic patients exhibit a reduction in β cells, which secrete insulin to help regulate glucose homeostasis; however, little is known about the factors that regulate proliferation of these cells in human pancreas. Access to primary
Bricout-Neveu, Emilie +10 more
core +4 more sources
Betatrophin—Promises Fading and Lessons Learned [PDF]
The discovery of a potent mitogen for insulin-producing pancreatic β cells, optimistically termed "betatrophin," excited researchers and laypeople alike, promising a new therapeutic approach to diabetes. A recent "Matters Arising" report by Gusarova and colleagues (2014) places serious doubts on whether "betatrophin" plays any major role in β cell ...
openaire +2 more sources
Variation in Circulating Betatrophin/ ANGPTL8 Levels in Normal and Overweight/Obese Pregnant Women [PDF]
Introduction: Betatrophin as hepatokine and adipokine influences glucose homeostasis and implicates in the pathophysiological process of obesity and pregnancy.
Mohammad Ahmad Hamza +2 more
doaj +1 more source

